0001493152-23-002020.txt : 20230120 0001493152-23-002020.hdr.sgml : 20230120 20230120160547 ACCESSION NUMBER: 0001493152-23-002020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230118 FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sassi Nir CENTRAL INDEX KEY: 0001760673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 23541005 MAIL ADDRESS: STREET 1: 3 ELUL STREET, APT. 6 CITY: MODIIN STATE: L3 ZIP: 7176397 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (646) 427-2727 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0306 4 2023-01-18 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001760673 Sassi Nir C/O INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.61 2023-01-18 4 A 0 40000 0 A 2033-01-18 Common Stock 40000 40000 D The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026. /s/ Nir Sassi 2023-01-20